Clinical Trial: START - Early Thrombocyte Administration to Patients With Ruptured Abdominal Aortic Aneurism

Study Status: Recruiting
Recruit Status: Unknown status
Study Type: Interventional

Official Title: Thrombocyte Administration Versus no Thrombocytes to Patients With Ruptured Abdominal Aortic Aneurism Before Transport to Hospital With Vascular Surgical Department

Brief Summary: The purpose of this study is to investigate the effect of platelet infusion prior to transfer to a vascular surgical department in patients with a ruptured abdominal aortic aneurism.

Detailed Summary:
Sponsor: Rigshospitalet, Denmark

Current Primary Outcome: Mortality [ Time Frame: 30 days ]

Mortality during the first 30days after randomization, and time to death during the 30 days.


Original Primary Outcome: Same as current

Current Secondary Outcome:

  • Acute myocardial infarction [ Time Frame: 30 days ]
    Development of AMI during the first 30 days after randomization, and the time to development during the first 30 days.
  • Post operative kidney failure [ Time Frame: 30 days ]
    The need for dialysis during the first 30 days, time to start of dialysis and length.
  • Post operative pulmonary insufficiency [ Time Frame: 30 days ]
    Length of respirator treatment in the ICU during the first 30 days.
  • Length of stay in ICU [ Time Frame: until discharged from ICU ]
    Length of stay in ICU
  • Length of stay in hospital [ Time Frame: until discharged from hospital ]
    Until discharged from main surgical department or if transferred to local hospital, when the patient leave local hospital.


Original Secondary Outcome: Same as current

Information By: Rigshospitalet, Denmark

Dates:
Date Received: February 7, 2011
Date Started: March 2010
Date Completion: March 2015
Last Updated: March 13, 2013
Last Verified: March 2013